Skip to content

The Community Navigator trial to reduce loneliness and depression in adults with depression that does not respond to drug treatment

Randomised controlled trial of the Community Navigator programme to reduce loneliness and depression for adults with treatment resistant depression in secondary mental health services

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN13205972
Enrollment
306
Registered
2022-07-08
Start date
2022-07-15
Completion date
Unknown
Last updated
2026-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression Mental and Behavioural Disorders

Interventions

Current interventions as of 03/02/2026: This is a researcher-blind, randomised controlled trial with two arms. Staff in participating NHS services will briefly describe the study to potentially elig
then take formal consent from those who wish to take part. All consenting, potential participants will then be screened by researchers for loneliness and meeting treatment resistant depression criteri

Sponsors

Camden and Islington NHS Foundation Trust
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age 18+ years 2. Meet ICD-10 diagnostic criteria for depression assessed using the Clinical Interview Schedule - Revised (CIS-R) interview 3. Have had at least two reported courses of anti-depressants without symptom remission, confirmed by the participant 4. Score of 2 or more on 6-item De Jong Gierveld Loneliness Scale (DJG-6)

Exclusion criteria

Exclusion criteria: Current exclusion criteria as of 28/11/2024: 1. Are due to be discharged from the mental health team within the trial intervention period (8 months) 2. Currently using mental health inpatient services 3. Identified by involved clinicians or clinical records as having a primary diagnosis of a serious mental illness other than TRD, defined as schizophrenia or other non-mood psychotic disorders (ICD-10 codes F20-29 or equivalent) or bipolar disorder (ICD-10 code F31 or equivalent), or a diagnosis of dementia (ICD-10 codes F00-F03 or equivalent) or mild cognitive impairment (ICD-10 code F06.7 or equivalent) 4. Lacks capacity to consent to participate 5. Does not understand English well enough to give informed consent and engage with the study intervention 6. Has a care coordinator who supervises the Community Navigators _____ Previous exclusion criteria: 1. Are due to be discharged from the mental health team within the trial intervention period (8 months) 2. Currently using mental health inpatient services 3. Identified by involved clinicians or clinical records as having a primary diagnosis of a serious mental illness other than TRD, defined as schizophrenia or other non-mood psychotic disorders (ICD codes F20-29) or bipolar disorder (ICD code F31) 4. Lacks capacity to consent to participate 5. Does not understand English well enough to give informed consent and engage with the study intervention 6. Has a care coordinator who supervises the Community Navigators

Design outcomes

Primary

MeasureTime frame
Depression severity (PHQ-9) at 8 months (end-of-treatment)

Secondary

MeasureTime frame
1. Depression severity (PHQ-9); Timepoint(s): baseline, 4, 11, and 14 months 2. Number of patients achieving a 20% reduction in PHQ-9; Timepoint(s): Baseline, 8 and 14 months 3. Number of patients who achieve remission of depressive symptoms, defined as a PHQ-9 score of <10; Timepoint(s): Baseline, 8 and 14 months 4. Loneliness (ULS-8); Timepoint(s): Baseline, 4, 8, 11, and 14 months 5. Anxiety (GAD-7); Timepoint(s): Baseline, 8 and 14 months 6. Process of Recovery (QPR); Timepoint(s): Baseline, 8 and 14 months 7. Four-item Multiple Identities Scale (MIS); Timepoint(s): Baseline, 8 and 14 months 8. Brief Rosenberg self-esteem scale (B-RSES); Timepoint(s): Baseline, 8 and 14 months 9. Self-stigma (DISC-12 sub-scale); Timepoint(s): Baseline, 8 and 14 months 10. Lubben Social Network Schedule (LSNS-6); Timepoint(s): Baseline, 8 and 14 months 11. EuroQol EQ-5D 5 level (EQ-5D-5L); Timepoint(s): Baseline, 8 and 14 months 12. Recovering Quality of Life (ReQoL); Timepoint(s): Baseline, 8 and 14 months 13. Client Service Inventory (CSRI); Timepoint(s): Baseline, 8 and 14 months 14. Daytime Activities Questionnaire; Timepoint(s): Baseline, 4, 8, 11, and 14 months

Countries

England, United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 19, 2026